Candel Therapeutics’ Stock Gains Momentum as Viral Immunotherapy Shows Promise in Cancer Treatment
Candel Therapeutics, Inc., a biotechnology company in a late clinical stage, is making strides in the development and commercialization of viral immunotherapies aimed at treating